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ABSTRACT: Epiglottitis is an acute. life threatening 
infection usually caused by Haemophilus infiuenzae 
type b. Although antibiotic therapy is an important part 
of management. the optimal route and duration is 
unknown. A multicentre retrospective review of 305 
children wHh epiglottitis was carried out in order to 
relate antibiotic therapy to hospital course and out-
come. as well as to examine regional variation in patient 
demographics. clinical presentation and course of dis-
ease. A standardized form was used to extract data from 
hospital records. Although management varied signifi-
canlly among the sLx centres in terms of mean duration 
of intubation (46 to 81 h). intravenous antibiotic therapy 
(3.8to 5. 7 days) and hospital stay (5.3 to 8.4 days). there 
were no s ignificant centre-related differences in epid-
emiology. clinical course or outcome of cpiglollitis. An 
EPIGLOTI'ITIS IS AN ACUTE. LIFE THREATENING ILL-ness caused almost exclusively by Haemo-
philus injluenzae type b . The majority of cases are 
in children younger than five years of age, with a 
peak incidence at age two to four years ( 1- 1 7). 
Respiratory distress with impending acute ob-
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exlraepiglotlic focus of infection was present in 15% of 
patients and included three with septic arthrttis and one 
with meningitis. The duration of fever in hospital and 
maximum recorded temperature in hospital were s ig-
nificanlly g reater for children with extraepiglollic infec-
tion compared to those \vilh epiglottitis alone. The data 
presented in this review suggest that most children with 
epiglottitis have an uncomplicated course and respond 
ra pidly to antimicrobial therapy follo\ving airway secure-
ment. A short period of intravenous and oral antibiotic 
therapy is likely adequate for most children \'lith epiglot-
titis. A well designed multicenlre prospective Liial is still 
needed to determine the optimal duration of antibiotic 
therapy. Can J Infect Dis 1990;1(1):15-22 
Key Words: Epiglottitis. Haemophilus influenzae type b 
struction is the most notable clinical presentation, 
but evidence of systemic infection \vith fever and 
leukocytosis is also present in the majority of 
cases. Although securing an airway is essential in 
the immediate management of epiglottitis. the use 
of parenteral antibiotics is also a mainstay of 
therapy since bacteremia is documented in 60 to 
90% of cases. 
The appropriate duration of total as well as 
parenteral antibiotic therapy for epiglottitis has 
not been addressed in controlled randomized pro-
spective studies. A search of the literature re-
vealed a variety of suggested therapeutic regimens 
providing a total antibiotic course of seven to 10 
days (5.8.12,13). Specific recommendations for 
duration of intravenous therapy varied from 24 h 
after e ither admission (18) or extubation (19). to 
seven days (20-22). Data supporting these ap-
proaches were not found. Prior to the development 
of a prospective therapeutic trial. a retrospective 
study in six different Canadian centres was con-
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Figure 1) Centre specific monthly distribution q{cases determined using years for which the entire calendar year was 
available: StJohn's 1984·87: Halifax 1980 86: Montreal1982 85: Ottawa 1984·88: Winnipeg 1981 ·85: and Saskatoon 
198285 
dueled to relate pattern of antimicrobial therapy 
to hospital course and outcome. Aside from the 
unique focus on antimicrobial therapy. this 
review represents the first large series of 
children with epiglottitis from diverse areas of 
Canada in tem1s of location. population density 
and urbanization. 
PATIENTS AND METHODS 
The hospital records of children with a dis -
charge diagnosis of epiglottitis were reviewed in 
the following cen trcs for the years as specified: 
Charles A Janeway Child Health Centre (I 66 
beds: referral base 500.000) in St John's. New-
foundland (September 1983 to June 1988): lzaac 
Walton Killam llospital for Children (233 beds: 
referral base 800.000) in Halifax. Nova Scotia 
(January 1980 December 1986): Montreal Chil-
dren's Hospital (214 beds: referral base 
3.000.000. shared with one other children's hos-
pital) in Montreal. Quebec (April 1981 March 
1986}: Children's Hospital ofEastem Ontario (230 
beds: referral base 1.000.000) in Ottawa. Ontario 
(May 1982 to June 1986): Winnipeg Children's 
llospital (150 beds: re ferral base 1.200.000) in 
Winnipeg. Manitoba (February 1980 October 
1986): and University llospital (96 pediatric beds 
in a general hospital: referral base 500.000) in 
Saskatoon. Saskatchewan (July 1977 to Septem-
ber 1986). 
Data were extracted from each record using a 
standardized reporting form which included 
demographic data. presenting symptoms includ-
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ing initial management prior to arrival at the ad-
mitting hospital. management and course while in 
hospital. laboratory investigations. subsequent 
management and follow-up a fte r discharge from 
hospital. 
Definite epigloltitis was defined as a charac-
teristic clinical presentation with direct visual evi-
dence of acute inflammation of the epiglottis 
a nd /or a positive blood culture for H influenzae 
type b. Probable epiglottitis was defined as typical 
c linical symptoms with evidence of an enlarged 
epiglottis or arycpigloltis on radiograph of the 
lateral neck in the absence of both direct visual-
ization of the epiglottis and a positive blood cul-
ture. Supraglotlitis was defined as a typical clin-
ical syndrome in which. on direct visual 
inspection. the epiglottis was normal but the ary-
epiglollis and surrounding area were inflamed 
and edematous. irrespective of culture results. In 
order to determine duration of antibiotics given in 
hospital by intravenous as well as oral routes. the 
actual number of doses of each antibiotic was 
counted and indicated on the data form along with 
the dosing interval. The duration for each drug by 
a specific route was defined as the number of 
doses multiplied by one twenty-fourth of the 
dosing interval. The duration of antibiotics follow-
ing discharge was estimated from the interval 
specified on discharge orders. 
Standard statistical methods were used to ana-
lyze differences between centres with respect to 
presentation of illness. results oflaboratory inves-
tigations and management in hospital. 
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RESULTS 
Patient population/ demographic variables: A 
total of 311 charts were re,'iewed: 31 from St 
John·s. 61 from I lalifax. 66 from Montreal. 47 from 
Ottawa. 79 from Winnipeg and 27 from Saskatoon. 
Six cases were eliminated on the basis of age ( 16 
years or older) or diagnosis: three adu lts from 
Saskatoon (the only centre which admitted 
adulls). and three cases in which the diagnosis of 
epiglottitis was not confirmed on chart review. 
TI1ese included one case with croup (llalifax). one 
with retropharyngeal abscess (Winnipeg) and one 
wilh suspected epiglottitis who was hospitalized 
for less than 24 hand in whom chest and lateral 
neck radiographs were nonnal and blood cultures 
negative (Saskatoon) . Of the remaining 305 cases. 
291 were drfined as definite epiglottitis. sLx as 
probable epiglottitis and eight as supraglotlitis. 
The mean +standard deviation fo r patient age 
was 44.8:±-26.6 months with a range of four to 176 
months. The peak age of occurrence was from 25 
to 48 months (48% of cases). The age distribution 
did not vary significantly between centres. The 
proportion of cases potentially preventable by ad-
ministration of II injluenzae type b conjugate vac-
cine at 18 months of age was 92% overall with a 
range of 8 1 to lOO% between centres. 
The male/female ratio was 1.39. There was an 
excess of males in all centres except Ottawa where 
the ratio was 0.88. Information concerning race 
was available for 59% of cases. These were pre-
TABlE 1 
Prevalence of presenting symptoms in Canadian 
children with epigloHitis 
Total group Low Previously 
estimate reported 
range among range 
c entres (1- 12) 
High Low 
estimate estimate 
Fever 93% 89% 89-93% (5)" 60-100% 
Dyspnea 87% 83% 79-87% (5) 15100% 
Sore throat 81% 69% - (0) 20-82% 
Odynophag•a 87% 56% 76-77% (2) 26-90% 
Drool 58% 53% 44-60% (4) 2-91% 
Stridor 55% 48% 40-64%{?) 26-93% 
URI 42% 39% 31-55% (5) 22-26% 
Hoarseness 38% 30% 15%(1) 4-38% 
EmeSis 28% 25% 15-35% (5) 25% 
COU9h 27% 24% 14-35% (4) 6-40% 
Hl(lh est.moro colculotron rncluded rn the denomrnolor only potrents tor 
whom absence or presence of symptoms wos spocrhed on the repon 
101m. Jaw esrrmur~ co•culo11(){1 usect the toto: group (n=J05) os tile 
aenomrnotO! The range of centre·spec•trc: symptom prevalence ,s gtven 
tO! centres rn lvlliCh presence or oosence or symptoms wos specrlred 10! 
of least 90% ot paTients • Numbel or centres quotrtyrng URI Upper 
IOSPIIOIOry rnfec lion 
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dominantly Caucasia n (94%) wilh the remainder 
being Black and Oriental. There were no Amer-
indian cases identified. The O\'{'rall and cemre-
specific distributi~ns of cases by month arc shown 
in Figure 1. 
Presentation of illness: The prevalence of pre-
senting symptoms is s hown in Table 1. The median 
duration of illness (90th percentile: range) prior to 
admission was 1.0 (5.0: 0. 1 to 48) days. Cor-
responding values for ind ividual symptoms were: 
upper respiratory infection 3.0 (7: 0 to 21): cough 
1.0 (7: 0. l to 3.0): fever 0.6 (2.0: 0. 1 to 7.0): sore 
throat 0.5 (2.0; 0 . l to 14): odynophagia 0.5 (I .0: 
0.1 to 4): hoarse voice 0.3 (1.0; 0.1 to 3): emesis 
0.3 ( 1.0: 0.1 to 2): drooling 0.2 (0.8: 0. 1 to 2): 
dyspnea 0.2 (0.5: 0. 1 to 5.0): and stridor 0.2 (0.5: 
0.1 to 4) . Prior to admission. 1 13 children (40%) 
were seen by a physician. A diagnosis of epiglottitis 
was made for 34% of the children seen. One or 
more doses of antibiotics were received bv 23% of 
the children prior to arTival at the admilti~g hospi-
tal. There were no sign ificant d iffe rences between 
the six centres for any of these parameter::; 
(ANOVA: P>O.l). 
Therapy for epiglottitis was initiated at a loca-
tion other than the admitting hospital for 1 18 
(39%) children . including another h ospital for 
109. a physician·s office for six and ·not stated· in 
three. Among the 109 patients first seen at a 
referring hospital. airway management prior to 
transfer included none in 39%. intubation in 51 0/o 
and tracheotomy in 5%: 12% were reported to 
have had respiratory atTest. Thr proportion of 
referred patients varied signifieanlly between cen-
tres: Montreal 18%: Ottawa 38°1o: St John·s 39°1o: 
l lalifax 40%: Winnipeg 50%: and Saskatoon 560;o 
(x2=35: P<O.OOOl). 
The initial assessment was performed at the 
admitting hospital for 187 (61 °1o) patients. Res-
piratory arrest occurred in 2%. In the majority of 
instances. the patients were transferred immedi-
ately to the intensive ca re unit or operati ng room. 
a nd th us there was little infommlion as to status 
when seen in the emergency dcpariment. Fever 
(temperature greater than 38oC) was documented 
in 60%. 
Airway management in hospital: Overall. 93% of 
cases were intubated. 3% had a tracheostomy and 
4% were observed. None of the patients who were 
initially observed required intubation. The major-
ity of int ubations were done in the operating room. 
primarily by an anesthetist. Accidental extubation 
occutT<.'cl in nine cases (3%). seven of which were 
rc-intubated. No complications secondary to acci -
dental extubation were reported . 
The centre-specific lime to extubation is shown 
in Figure 2. The mean duration of intubation was 
17 
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56±23 h (range 17 to 188) for the entire group. 
There was significant variation between centres 
for this parameter with centre means ± SO as 
fol lows: Ottawa46± 15. Halifax48 ±20: Winn ipeg 
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Figure 2) Centre-spec(fic duration of intubation (top): 
antibiotics (middle): and hospital stay {bottom) for 305 
childr·en w ith acute epig loltitis. The signiJ'icant di.[feren-
ces between centres for each parameter are discussed in 
the text 
18 
52 ± 16; Saskatoon 61 ± 23: Montreal62 ± 16: and 
S t John·s 81 ± 44 (ANOVA: P<O.OOO 1). 
Post extubation complications included: stridor 
in 21%. atelectasis in 4%, pneumonia in 2% and 
wheeze in 1%. Post extubation s tridor was re-
ported more frequenlly in children who were re-
ported to have had a two stage oral then nasal 
intubation (30% of 122) versus children with a 
single orolracheaJ (9% of 11) or nasotracheal ( 12% 
of 115) intubation procedure (x2=12.75; P=0.002). 
Stridor was mild. however. and responded in al l 
cases to medical management consisting of mist 
l11erapy and/or racemic adrenaline. Other com-
plications included one vallecular cyst. one laryn-
geal ulcer and one bruised larynx. 
Investigations in hospital: A white blood cell 
(WBC) count was determined shortly after admis-
s ion for 280 (92%) patients. Leukocytosis defined 
as total WBC greater than 10.0 x 109 /L was pre-
sent in 89% of patients. The elevation in total WBC 
was moderate to marked in most patients: 15 to 
20 x 109 /Lin 27%: 21 to 25 in 22%: 25 to 30 in 
13%: and more than 30 in 7%. The absolute band 
count was less than 0.5 x 109 / Lin 15%. 0.5 to less 
than 1.0 in 9%. 1.0 to 5.0 in 53% and more than 
5.0 in 23%. A plate let count was recorded for 71 % 
of cases and was nom1al in 99%. The mean hemo-
globin was 120 ±10 g/L. A value of less than 110 
was noted for 15%. 
Blood cultures were obtained for 292 (96%) 
pa tients and were posit ive in 82%. All but three of 
the 241 isolates were H injluenzae (99%). The 
exceptions (group B beta-hemolytic streptococ-
cus: Haemophilus parai'1fluenzae: peptococcus) 
a ll occurred as single b lood isolates in three Mon-
treal patients. All but eight of the H injluenzae 
isolates were typed , and of these, a ll were capsular 
type b. Receipt of antibiotics prior to admission 
s ignificantly decreased the likelihood that a blood 
culture would be positive. Only 56% (40 of 7 1) of 
patients given antibiotics prior to admission had 
positive b lood cultures versu s 91% (200 of220) of 
those who had not received prior treatment 
(x2=42.0: P<O.OOOl). Urine for rapid antigen de-
tection was obtained from only 28 patients and 
was positive for H injluenzae type b in 14. Test 
results suggested an e tiology of H injluenzae in 
four pa tients with negative blood cultures. Among 
H i'1fluenzae type b isolates. 24% were res istant to 
ampicillin. There were no significant centre-spe-
cific differences in the prevalence of ampicillin 
resistance: Halifax 20% (nine of 46). St John's 
36% (eight of22). Monlreal 24% (14 of 55), Ottawa 
28% (10 of 36). Saskatoon 20% (one of five). and 
Winnipeg 23% (16 of 69). 
Cultures of the epiglottis were obtained in 207 
pa tients. H injlLLenzae was recovered from 62%. H 
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parainjluenzae from 8%. Staphylococcus aureus 
from 11%. group A beta-hemolytic streptococcus 
from 3%. group B beta-hemolytic streptococcus 
from 0.5% and mixed normal pharyngeal flora 
from 14%. There was no growth in 15%. Beta-lac-
tamase activity was determined for paired b lood 
and epiglottis isolates in 58 of the 118 cases in 
which H injluenzae was isolated from both sites. 
Concordant results were obtained for 57 of 58 
(98%). In one case. the blood isolate was beta-lac-
tamase positive. whereas the epiglottis isolate was 
beta-lactamase negative. Most epiglottis H injluen-
zae isolates were not serotyped. and thus correla-
tion with blood culture results could not be assessed. 
Radiographs of the chest were obtained for 243 
children (80%) with reported results as follows: 
normal 52%. consolidation 29%. atelectasis 14%. 
pneumothorax 1%. pulmonary edema 1% and 
other abnormalities 4%. 
Radiographs of the lateral neck were obtained 
for 243 patients (80%) . Abnormalities were noted 
in 99% with findings typical of epiglottitis in 91%. 
aryepiglottic swelling only in 4%. subglottic swell-
ing in 1 o/o and uninterpretable changes in 3%. 
Antibiotic therapy: Al l but one patient received 
at least one dose of antibiotic intravenously while 
in hospital. Empiric therapy on admission con-
sisted of ampicillin and chloramphenicol in 8 1%. 
chloramphenicol alone in 10%. ampicillin a lone in 
1%. cefurox:ime in 5%, cefamandole in 1 o/o and 
miscellaneous in 1% (one ampicillin/cefotax:ime. 
one ampicillin/cloxacillin. and one chloramphen-
icol/cloxacillin). A s ingle patient was started on 
oral amoxicillin. This patient was observed in hos-
pital without intubation and had no blood culture 
taken. The diagnosis was based on a lateral neck 
radiograph which showed swollen aryepiglottic 
folds and a slightly swollen epiglottis. 
Eight patients were excluded from the analysis 
of duration of antibiotic therapy: four who died 
early in the hospital course and four with H in-
jluenzae bacteremia in whom the presence of 
meningitis (one patien t) or septic arthritis (three 
patients) determined the total du ration of therapy. 
For the group as a whole. the mean ± SO dura-
tion of intravenous antibiotics was 4.8 ± 2.2 days 
(range 1.3 to 18.5 days): hospital-monitored anti-
biotics (intravenous + oral) was 6.0 ± 2.3 days 
(range two to 19.5 days); and of estimated total 
antibiotics (hospital + planned discharge medica-
tions) was 9.9 ± 2.8 days (range two to 19.8 days). 
Oral antibiotics were started in hospital for 69% of 
patients; these included amoxicillin in 62%. chlor-
amphenicol in 27%. ampicillin in 7%. cefaclor in 
3% and an unspecified antistaphylococcal penicil-
lin in 1%. Orders for oral antibiotics following 
discharge were written for 73% of patients. The 
CAN J INFECT DIS VOL 1 No 1 M AY 1990 
Epiglottitis in Canada 
duration was specified for 186 of 209 patients 
(89%) and averaged 5.2 ± 2 .8 days. The drugs used 
were similar to those started in hospital. 
Centre variation in duration of antibiotic ther-
apy was analyzed for hospital-monitored therapy 
only. as compliance with discharge medication 
could not be determined. The duration (mean ± 
SO) of intravenous antibiotics was significantly 
shorter in Winnipeg (3 .8 ± 1.4 days) t han in Mon-
treal (5. 7 ± 2.2 days) . Ottawa (5.0 ± 1.5 days) and 
St John's (5.3 ± 2. 7 days) (P<0.05 by Tukey's 
studenlized range test). The durations in Halifax 
(4.8 ± 2.6 days) and Saskatoon (4. 7 ± 2.0 days) 
were not significantly different from the other cen-
tres. The centre-specific cumulative duration of 
intravenous antibiotics is shown in Figure 2 . The 
mean duration of intravenous plus oral antibiotics 
administered in hospital was also significantly 
shorter for patients from Winn ipeg (5.4 ± 1.5 days) 
compared with all other centres (6.6 ± 2.9; 6 . 7 ± 
2.8: 6.6 ± 2.1: and 6.8 ± 1.4 days) except Sas-
katoon (5.7 ± 1.8 days). The presence or absence 
of documented bacteremia had no s ignificant ef-
fect on the duration of either intravenous (4.9 ± 
2 .2 and 4.2 ± 1.8 days. respectively) or total hospi-
tal monitored antibiotics (6.1 ± 2.3 and 5.7 ± 2.2. 
respectively). 
Hospital course : During hospitalization. fever 
(temperature greater than 38°C irrespective of site 
of measurement) was documented in 88% of pa-
tients. The maximum recorded temperature in 
hospital occurred on the first day for 84% of 
patients. the second day for 10% and the third day 
or later for 6%. The mean duration of fever (defined 
as first hospital day afebrile minus one) was 1.9 ± 
1.3 days overall. 
The discharge diagnosis indicated an extraepi-
glottic focus of infection in 46 patients (15%) in-
cluding 25 pneumonia: 13 otitis media; three 
septic arthritis (one with associated osteomye-
litis): three cervical adenitis: one pharyngitis; one 
mediastinitis: one submandibular cellulitis; and 
one meningitis. Clinical data for the children with 
septic arthritis and meningitis are summariZed in 
Table 2. All four children had bacteremia with 
beta-lactamase negative H i'1fluenzae. and none 
had received antibiotics prior to admission. The 
duration of fever was significanUy longer (ANOVA: 
P<0.0001) in th e children with a second site of 
infection (2. 9 ± 1. 7 days) than in children with 
epiglollitis only (1.9 ± 1.1 days). The maximum 
recorded temperature in hospital equalled or ex-
ceeded 40°C in 33% of children with an extra-
epiglottic s ite of infection versus 13% of children 
with epiglottitis only (x2 test. P=0.002). The admit-
ting leukocyte count was not helpful in identifying 
children with a second focus of infection. 
19 
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TABLE 2 
Clinical data for four c hildren with a second invasive focus of infection accompanying epiglottitis 
Age Sex Days ill WBC Maximum First Recurre nt Extraepiglotlic site Hospital Diagnosis 
(years) PTA temperature C'C> afebrile day fever (day) day onset confirmed by 
20 M 2 18 9 40 3 4 Yes (?) Right knee ? Bone scan 
3.2 M 177 40 3 3 No Left elbow 6 Not slated 
63 F 7 16 9 39.8 6 No Right ankle and d1s- 5 Gallium scan 
tal tibia 
3.2 F 05 23.0 40 5 4 Yes (6) Meninges 4 CSF culture· 
PTA Pnor ro adm1ssion · Lumbar puncture done on adm1ss1on beca use o r lethargy Cerebrospina l flwd (CSF) hod zero cells and was culture negative 
Repeat CSF on the fourth hospital day hod 682 cells (98% polymorphonuclear leukocytes) and grew Haemophllus lnfluenzoe type b 
Four ch ildren died. for a case fatality rate of 
1.3%. In all four cases. cardiorespiratory arrest 
occurred prior to transfer and the triage s ite was 
120 km or more from lhe admitting hospita l. 
Respiratory arrest occurred in two of the children 
at time of presentation and. despi te resuscitation. 
death occurred within 5 a nd 18 h of admission to 
hospital. Post mortem information was not avail-
able. One chi ld had a la rge tens ion pneumothorax 
and subcutaneous emphysema of the neck. The 
other two had been managed as croup at a refer-
ring hospital for severa l hours prior to acute de-
terioration and transfer. Bolh of these children 
died two days after transfer. Post mortem ex-
amina tion confirmed the diagnosis of epiglottitis 
a nd provided evidence of hypoxic encephalopathy 
a nd pulmonary edema. 
Complications noted among survival-s included 
one bleeding stress ulcer . one feb1ile seizure. and 
one case of cerebral irritability related to a post-
opera tive med ication . 
DISCUSSION 
Despite the geographic separation a nd regiona l 
differences between the six centres included in 
this study. patient demographics. c linical presen-
tation . hospital course a nd outcome of acute epi-
glottitis. admitting labora tory data includ ing 
complete blood count a nd radiography. and etio-
logy including preva lence of ampici llin -resis tant H 
in.fluenzae type b were remarkably s imila r . A re-
cent review from Toronto's l lospita l for S ick Chil-
dren presented a s imilar clinical picture (12) . 
These results were not unexpected given the uni-
formity of presentation and course reported in 
review a rticles from severa l different countries. 
including the United States (2 -4.9- 1 I. l 7. I9). 
England (J 8). Austra lia ( I4) . New Zeala nd (7). 
Switzerland (8} and Sweden (15) . 
The primary focus of this review was to docu-
ment the duration of intravenous antibiotic ther-
apy currently practised in several Canadian 
centres and to determine whether or not a very 
short course of intravenous antibiotic was asso-
c ia ted with recurrent infection. Significant centre-
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re la ted differences in management were a pparent. 
with the s hortest course of both intravenous and 
hospita l-monitored a ntibiotic therapy employed in 
Winnipeg. Among 78 patients treated there. 63 
and 69%, respectively received intravenous anti-
b iotics for at most three days and s tayed in hos pi-
tal for no more than five days. The cor responding 
figu res for the entire series were 36 and 3 1%. 
respective ly. 
Recurrences of epiglottitis or other s ites of in-
fection were not documented for a ny of the chil-
dren in this series. Minor infeclions treated a t a 
physician's office or more serious infections man-
aged in a different hos pita l cou ld. however. have 
been missed. Rctu m visits a fter hospitalization for 
epiglottitis were recorded for 46% of the children 
reviewed. Problems potentially re lated to the acute 
illness were noted for only 2% of this group. a nd 
none of these were for recurrence of infection. A 
review of the literature revealed only one ins ta nce 
of readmission for recurrent ep iglottitis. This was 
one of 349 cases reported from Australia (1 4). The 
recurrence occurred in a ch ild who had been in 
hospital for 24 h only. 
The optimal duration of parenteral a nd hospi-
tal-monitored a ntibiolic therapy is unknown. Fac-
tors which may contribute to complications 
include the presence a nd magnitude of lhe bac-
teremia. as well as lhc presence or absence of a 
second focus of infection. Nearly a ll of the children 
reviewed ha d b lood cu ltures drawn. and 82% had 
documented bact eremia. For children who re-
ceived no oral a ntibiotics prior to admission. lhe 
prevalence of bacteremia was even highe r a t 9 1%. 
This is in agreement with the currenlly held view 
that most cases of clinical epiglottitis in chi ldren 
a re due to I-I iqfluenzae type b. and that bac-
teremia is probably universa lly present a t some 
time during the course of the illness. The mag-
nitude of bacteremia in epiglottitis is 10 to I 000 
colony forming u nits per mL. which is I to 10% of 
tha t found in I-I injluenzae type b meningitis (23) . 
This may expla in lhe reported range of 50 to 90% 
for positive blood cultures in epiglottitis. as well as 
the present observation of a significantly lower 
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prevalence of documented bacteremia (56%) 
among the 71 ch ildren in this series who received 
oral antibiotics prior to admission. J<'urthennore. 
the rarity of reported concurrent sites of invasive 
infection - including meningitis. septic arthritis 
and cellulitis (24.25) - support the concept that 
bacteremia is not a major part of the paU1ogenesis 
of epiglotlitis but probably develops secondarily to 
the marked degree of inflammation of the epiglot-
tis and surrounding structures in conjunction 
with mucosal colonization. This line of reasoning 
would support a relatively short duration not only 
of parenteral but also of total antibiotic therapy. 
The majority of the 233 (76%) children in this 
series who had no extraepiglottic sites of infection 
identified during the hospital course had a very 
rapid defervescence over two lo four days. In this 
subgroup. one or two daily doses of an antibiotic 
with a long half-life. such as ceftria.xone. given for 
the duration of endotracheal tube placement and 
followed by a few days of oral antibiotics. may be 
sufncicnt. 
For children with a second focus of infection. 
the length and type of antibiotic therapy would 
depend upon the specific site of ex.1.raepigiottic 
infection. As noted above. most reviews of epiglot-
titis stress the low frequency of secondary sites of 
infcclion. The most extensive review to date was 
done by Molteni (24) who reported a 25% in-
cidence of both pneumonia and cervical lymph-
adenitis. 8% pharyngiUs and 5% otitis media 
among 72 patients from his own institution. The 
reported incidence of concurrent pneumonia ran-
ges from I to 50%. Unfortunately. the validity of a 
clinical diagnosis of pneumonia versus atelectasis 
is impossible to establish in a retrospective review. 
For the 305 patients in th is review. a diagnosis of 
pneumonia was based on a slated discharge diag-
nosis as well as x-ray findings. and thus the 
observed rate of 8% may have underestimated the 
true incidence. 
There have been at least one dozen reported 
cases of concurrent epiglottitis and meningitis. To 
the authors· knowledge. septic arthritis and os-
teomyelitis have not previously been reported as 
accompanying epiglottitis . In one of the three chil-
dren in the present series. the diagnosis was only 
suspected after six days in hospital. at which lime 
the patient was afebrile: the hospital course had 
been uncomplicated. The other two children with 
septic arthritis and the one with meningitis had 
unusual hospital courses with fever which was 
either slow to resolve or recurrent after an afebrile 
period. These cases. although infrequent. must be 
considered In determining the optimal duration 
and route of antibiotic therapy and the period of 
observation in hospital. Investigation to nile out a 
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second focus of in fcclion should be carefully con-
sidered in children with fever exceeding 40°C or 
persisting four days or more after admission to 
hospital. 
The data gathered in this review raise questions 
about issues other than rate and duration of a n-
tibiotic therapy. As shown in Table 1. the reported 
prevalence of presenting symptoms for epiglotlilis 
varies over a wide range even for the classically 
recognized tetrad of dyspnea. drool. dysphagia 
and altered voice. This finding likely follows from 
the unreliable nature of retrospective reviews. In 
most reports. it is impossible to tell whether or not 
the absence of a given symptom relates to absence 
of recorded data or absence of a clinical finding. A 
recent report of four cases of 'atypical' epiglottitis 
stressed that children may present with a more 
gradual illness evolving over several days with 
symptoms. such as cough and hoarse voice. that 
arc more usually associated \vith croup (26). Al-
though acute onset of respiratory distress oc-
curred in most children in this ser·ies. several had 
been ill for two to five days and 24% of the group 
had been seen by a physician prior to presentation 
at hospital with an illness that was not diagnosed 
as cpiglotutis. Furthermore, one of the four deaths 
occun·ed in a chi ld who had a sudden respiratory 
arrest while being managed as croup at a referring 
hospital. A prospective study of epiglottitis would 
give a much clearer picture of the natural h istory 
immediately preceding the acute onset of res-
piratory distress. Nevertheless. the data presented 
here serves to emphasize that an ·atypical' presen-
tation of epiglottitis evolving over a few days is 
perhaps more common than previously acknow-
ledged. 
Most of the data from this series regarding 
airway management. including the lack of sig-
nificant com plical ions associated with intubation. 
is consistent with previous reports. The increased 
incidence of post extubation stt;dor associated 
with a two stage orotracheal to nasotracheal in-
tubation was unexpected. The retrospective na-
ture of the study with lack of an objective 
definition of stridor makes any conclusion to be 
drawn from this finding tenuous. Nevertheless. 
given the degree of inflammation and edema 
which accompanies acute epiglottitis. the pos-
sibility of greater damage with a two stage intuba-
tion procedure deserves further study. 
The wide variety of bacterial isolates recovered 
from cullure swabs of the epiglottis as well as the 
one instance in which an an1picillin-sensitive H 
injluenzae was isolated from the epiglottis 
whereas an ampicillin-resistant 11 i'1fluenzae was 
recovered from blood. underscores the lack of 
reliability of epiglottis cultures for determining 
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antibiotic choice. In the absence of a blood isolate. 
management with a beta-lactamase stable anti-
biotic should be continued, irrespective of the 
sensitivity of isolates from the epiglottis. 
In conclusion. this review provides baseline 
data on the clinical presentation and course of 
epiglottitis in children from several regions of 
Canada. As with other retrospective reviews of 
epiglottitis. it raises many questions. Despite a 
multitude of reviews of epiglottitis over the past 
four decades involving nearly 4500 children. there 
remain many unresolved issues surrounding the 
pathogenesis. natural history and management of 
epiglottitis. These could potentially be addressed 
in a multicentre prospective therapeutic u;al com-
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